HK1204947A1 - Sterilized composition - Google Patents

Sterilized composition

Info

Publication number
HK1204947A1
HK1204947A1 HK15105620.0A HK15105620A HK1204947A1 HK 1204947 A1 HK1204947 A1 HK 1204947A1 HK 15105620 A HK15105620 A HK 15105620A HK 1204947 A1 HK1204947 A1 HK 1204947A1
Authority
HK
Hong Kong
Prior art keywords
sterilized composition
sterilized
composition
Prior art date
Application number
HK15105620.0A
Other languages
English (en)
Chinese (zh)
Inventor
景山由佳子
藤永賢太郎
山口鮎子
本多勧
佐竹真
兼子博章
‧石割
Original Assignee
Teijin Ltd
Teijin Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd, Teijin Pharma Ltd filed Critical Teijin Ltd
Publication of HK1204947A1 publication Critical patent/HK1204947A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01021—Beta-glucosidase (3.2.1.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01003—Triacylglycerol lipase (3.1.1.3)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Moulding By Coating Moulds (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
HK15105620.0A 2012-05-14 2015-06-15 Sterilized composition HK1204947A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2012110765 2012-05-14
JP2012110390 2012-05-14
JP2013040593 2013-03-01
PCT/JP2013/063868 WO2013172468A1 (fr) 2012-05-14 2013-05-13 Composition stérilisée

Publications (1)

Publication Number Publication Date
HK1204947A1 true HK1204947A1 (en) 2015-12-11

Family

ID=49583866

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15105620.0A HK1204947A1 (en) 2012-05-14 2015-06-15 Sterilized composition

Country Status (18)

Country Link
US (1) US10071061B2 (fr)
EP (1) EP2851085B1 (fr)
JP (1) JP5746430B2 (fr)
KR (1) KR102037555B1 (fr)
CN (1) CN104284673B (fr)
AU (1) AU2013261308B2 (fr)
BR (1) BR112014028443B1 (fr)
CA (1) CA2873602C (fr)
DK (1) DK2851085T3 (fr)
ES (1) ES2746300T3 (fr)
HK (1) HK1204947A1 (fr)
IN (1) IN2014DN09621A (fr)
MX (1) MX356545B (fr)
PL (1) PL2851085T3 (fr)
PT (1) PT2851085T (fr)
RU (1) RU2695522C2 (fr)
TW (1) TWI636799B (fr)
WO (1) WO2013172468A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2890098T3 (es) * 2012-05-14 2022-01-17 Teijin Ltd Moldeado de láminas y material hemostático
BR112016025331A2 (pt) 2014-04-30 2017-08-15 Matoke Holdings Ltd composições antimicrobianas
CN107708752A (zh) * 2015-02-03 2018-02-16 玛托克控股有限公司 抗微生物纤维和组合物
FR3036707B1 (fr) * 2015-05-29 2019-05-17 Maco Pharma Procede de sterilisation d'un lysat plaquettaire
GB201716986D0 (en) 2017-10-16 2017-11-29 Matoke Holdings Ltd Antimicrobial compositions
KR20210132054A (ko) 2019-01-31 2021-11-03 셀 메디신 가부시키가이샤 무기 염류 단백 복합 의료 기기

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2209937B (en) 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
JPH0622570B2 (ja) 1989-01-31 1994-03-30 多木化学株式会社 生体材料
US5225205A (en) 1989-07-28 1993-07-06 Debiopharm S.A. Pharmaceutical composition in the form of microparticles
CH679207A5 (fr) 1989-07-28 1992-01-15 Debiopharm Sa
US5439688A (en) 1989-07-28 1995-08-08 Debio Recherche Pharmaceutique S.A. Process for preparing a pharmaceutical composition
CA2033046C (fr) 1990-01-12 1999-08-03 Lowell Saferstein Procede de preparation de produits de cellulose oxydee et neutralisee et mode d'utilisation connexe
AU663328B2 (en) 1991-06-21 1995-10-05 Genetics Institute, Llc Pharmaceutical formulations of osteogenic proteins
CH683149A5 (fr) 1991-07-22 1994-01-31 Debio Rech Pharma Sa Procédé pour la préparation de microsphères en matériau polymère biodégradable.
GB9206509D0 (en) 1992-03-25 1992-05-06 Jevco Ltd Heteromorphic sponges containing active agents
US5730933A (en) * 1996-04-16 1998-03-24 Depuy Orthopaedics, Inc. Radiation sterilization of biologically active compounds
US5945128A (en) 1996-09-04 1999-08-31 Romano Deghenghi Process to manufacture implants containing bioactive peptides
GB2344519B (en) 1998-12-07 2004-05-19 Johnson & Johnson Medical Ltd Sterile therapeutic compositions
US8076448B2 (en) 2006-10-11 2011-12-13 Tolmar Therapeutics, Inc. Preparation of biodegradable polyesters with low-burst properties by supercritical fluid extraction
EP2079767B1 (fr) * 2006-10-11 2014-08-27 Tolmar Therapeutics, Inc. Préparation par extraction avec un fluide supercritique de polyesters biodégradables ayant des propriétés de faible pic de libération immédiate
US8076294B2 (en) * 2007-08-01 2011-12-13 Advanced Technologies And Regenerative Medicine, Llc. Collagen-related peptides and uses thereof
US20100151033A1 (en) 2008-12-15 2010-06-17 Novartis Ag Octreotide depot formulation with constantly high exposure levels
KR20110133599A (ko) * 2009-03-10 2011-12-13 메드프린 리제너레이티브 메디컬 테크놀러지스 컴퍼니 리미티드 인공 경질막 및 인공 경질막의 제조방법
JP5555928B2 (ja) 2009-08-28 2014-07-23 日本バイリーン株式会社 酵素含有ナノファイバーの製造方法、酵素含有ナノファイバー、この酵素含有ナノファイバーを含む不織布及びこの不織布を用いた反応装置
WO2011138974A1 (fr) * 2010-05-07 2011-11-10 帝人株式会社 Matériau de renforcement pour une colle biologique, et procédé de production de celui-ci
US8273369B2 (en) 2010-05-17 2012-09-25 Ethicon, Inc. Reinforced absorbable synthetic matrix for hemostatic applications
BR112012030455B1 (pt) * 2010-06-01 2021-08-17 Baxter Healthcare S.A. Processo para fabricar uma composição hemostática seca e estável, recipiente acabado final, e, kit para administrar uma composição hemostática
JP5792442B2 (ja) * 2010-09-01 2015-10-14 帝人株式会社 細胞特異的ペプチドを含有する繊維構造体

Also Published As

Publication number Publication date
US20150125511A1 (en) 2015-05-07
BR112014028443A8 (pt) 2018-02-06
RU2695522C2 (ru) 2019-07-23
TWI636799B (zh) 2018-10-01
EP2851085A4 (fr) 2015-04-15
BR112014028443B1 (pt) 2021-01-19
CN104284673A (zh) 2015-01-14
JPWO2013172468A1 (ja) 2016-01-12
KR102037555B1 (ko) 2019-10-28
TW201350147A (zh) 2013-12-16
AU2013261308A1 (en) 2014-12-04
BR112014028443A2 (pt) 2017-06-27
CA2873602A1 (fr) 2013-11-21
ES2746300T3 (es) 2020-03-05
DK2851085T3 (da) 2019-09-09
IN2014DN09621A (fr) 2015-07-31
WO2013172468A1 (fr) 2013-11-21
MX2014013818A (es) 2015-05-11
PL2851085T3 (pl) 2019-12-31
JP5746430B2 (ja) 2015-07-08
CA2873602C (fr) 2022-08-16
MX356545B (es) 2018-06-01
US10071061B2 (en) 2018-09-11
CN104284673B (zh) 2018-02-13
EP2851085B1 (fr) 2019-06-26
PT2851085T (pt) 2019-10-11
RU2014150498A (ru) 2016-07-10
EP2851085A1 (fr) 2015-03-25
AU2013261308B2 (en) 2018-02-08
KR20150023253A (ko) 2015-03-05

Similar Documents

Publication Publication Date Title
GB2506426B (en) Composition
EP2897613A4 (fr) Compositions de traitement
PL2804487T3 (pl) Kompozycja
ZA201500519B (en) Composition
HK1207989A1 (en) Composition
EP2878295A4 (fr) Composition
GB201218954D0 (en) Composition
GB2498803B (en) Composition
HRP20190326T1 (hr) Pripravak
HK1199198A1 (en) Composition
HK1204947A1 (en) Sterilized composition
GB201206035D0 (en) Composition
ZA201407419B (en) Composition
EP2837670A4 (fr) Composition contenant un fluorobiphényle
HK1210966A1 (en) Misprostol composition
HRP20190033T1 (hr) Pripravak
EP2910538A4 (fr) Composition d'agent générant du gaz
EP2910537A4 (fr) Composition d'agent générant du gaz
GB201209597D0 (en) Composition
GB201208133D0 (en) Composition
GB201311517D0 (en) Composition
GB201219383D0 (en) Composition
GB201218195D0 (en) Composition
HK1204230A1 (en) Composition
GB201223526D0 (en) Composition